Because they are smaller, these nanovectors are easier to deliver into target cells. Their reduced size often translates to higher "transfection efficiency," meaning more cells successfully take up and use the DNA.
The move toward smaller, "smarter" vectors is driven by three primary needs in modern medicine and research: nsmart
At its core, nSMARt is a minimally sized DNA nanovector. The name is derived from "SMAR" (Scaffold/Matrix Attachment Region), which is a specific DNA sequence that helps organize the structure of chromatin within a cell’s nucleus. By utilizing these regions, scientists can create vectors that remain —meaning they stay as separate, self-replicating DNA entities outside the host's main chromosomes—while still producing high levels of the desired protein over long periods. The Evolution from pSMAR to nSMARt Because they are smaller, these nanovectors are easier
nSMARt was created by stripping away unnecessary bacterial sequences and reducing the "backbone" of the DNA. In some studies, this led to a 17.41% reduction in size , resulting in a vector as small as 431 base pairs. Key Benefits of nSMARt Technology The name is derived from "SMAR" (Scaffold/Matrix Attachment
By providing a safer, non-integrating alternative to viruses, these nanovectors could potentially treat genetic diseases by delivering "healthy" versions of genes directly to a patient's cells.